The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake

Brain Research

Volumn 1227, Issue , 2008, Pages 42-51

  Wu, Zhi Liang ^a   O'Kane, Teresa M ^a   Connors, Thomas J ^a   Marino, Michael J ^a   Schaffhauser, Hervé ^a  

^a CEPHALON INC   (United States)

Author keywords

ALX 5407; Glycine uptake; GlyT1; LY 294002; PI3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ALANINE; ALX 5407; GLYCINE; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; NEUROTRANSMITTER; ORG 25543; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE B; SARCOSINE; UNCLASSIFIED DRUG; WORTMANNIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL LINE; CONTROLLED STUDY; EMBRYO CELL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT;

RATTUS;

EID: 48949097118     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.078     Document Type: Article

References (48)

1. Adams R.H., Sato K., Shimada S., Tohyama M., Puschel A.W., and Betz H. Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. J. Neurosci. 15 (1995) 2524-2532
2. Adi S., Wu N.Y., and Rosenthal S.M. Growth factor-stimulated phosphorylation of Akt and p70(S6 K) is differentially inhibited by LY294002 and Wortmannin. Endocrinology 142 (2001) 498-501
3. Atkinson B.N., Bell S.C., De Vivo M., Kowalski L.R., Lechner S.M., Ognyanov V.I., Tham C.S., Tsai C., Jia J., Ashton D., and Klitenick M.A. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol. Pharmacol. 60 (2001) 1414-1420
4. Aubrey K.R., and Vandenberg R.J. N[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. Br. J. Pharmacol. 134 (2001) 1429-1436
5. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42 (1995) 674-683
6. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
7. Caulfield W.L., Collie I.T., Dickins R.S., Epemolu O., McGuire R., Hill D.R., McVey G., Morphy J.R., Rankovic Z., and Sundaram H. The first potent and selective inhibitors of the glycine transporter type 2. J. Med. Chem. 44 (2001) 2679-2682
8. Chen H.S., and Lipton S.A. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. 499 Pt 1 (1997) 27-46
9. Chen L., Muhlhauser M., and Yang C.R. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J. Neurophysiol. 89 (2003) 691-703
10. Copeland R.A. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists (2005), Wiley-Interscience, Hoboken, New Jersey
11. Cubelos B., Gimenez C., and Zafra F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb. Cortex 15 (2005) 448-459
12. Debler E.A., and Lajtha A. High-affinity transport of gamma-aminobutyric acid, glycine, taurine, l-aspartic acid, and l-glutamic acid in synaptosomal (P2) tissue: a kinetic and substrate specificity analysis. J. Neurochem 48 (1987) 1851-1856
13. Eulenburg V., Armsen W., Betz H., and Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci. 30 (2005) 325-333
14. Evans J., Herdon H., Cairns W., O'Brien E., Chapman C., Terrett J., and Gloger I. Cloning, functional characterisation and population analysis of a variant form of the human glycine type 2 transporter. FEBS Lett 463 (1999) 301-306
15. Fedele E., and Foster A.C. [3H]glycine uptake in rat hippocampus: kinetic analysis and autoradiographic localization. Brain Res. 572 (1992) 154-163
16. Fletcher E.J., and Lodge D. Glycine reverses antagonism of N-methyl-d-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by d-2-amino-5-phosphonovalerate (d-AP5) on rat cortical slices. Eur. J. Pharmacol. 151 (1988) 161-162
17. Fukasawa Y., Segawa H., Kim J.Y., Chairoungdua A., Kim D.K., Matsuo H., Cha S.H., Endou H., and Kanai Y. Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral d- and l-amino acids. J. Biol. Chem. 275 (2000) 9690-9698
18. Gomeza J., Zafra F., Olivares L., Gimenez C., and Aragon C. Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells. Biochim. Biophys. Acta 1233 (1995) 41-46
19. Gomeza J., Ohno K., and Betz H. Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises. Curr. Opin. Drug Discov. Dev 6 (2003) 675-682
20. Gomeza J., Armsen W., Betz H., and Eulenburg V. Lessons from the knocked-out glycine transporters. Handb. Exp. Pharmacol. (2006) 457-483
21. Harsing Jr. L.G., Gacsalyi I., Szabo G., Schmidt E., Sziray N., Sebban C., Tesolin-Decros B., Matyus P., Egyed A., Spedding M., and Levay G. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study. Pharmacol. Biochem. Behav. 74 (2003) 811-825
22. Herdon H.J., Godfrey F.M., Brown A.M., Coulton S., Evans J.R., and Cairns W.J. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes. Neuropharmacology 41 (2001) 88-96
23. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
24. Kawamoto J.C., and Barrett J.N. Cryopreservation of primary neurons for tissue culture. Brain Res. 384 (1986) 84-93
25. Kim K.M., Kingsmore S.F., Han H., Yang-Feng T.L., Godinot N., Seldin M.F., Caron M.G., and Giros B. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol. Pharmacol. 45 (1994) 608-617
26. Kinney G.G., Sur C., Burno M., Mallorga P.J., Williams J.B., Figueroa D.J., Wittmann M., Lemaire W., and Conn P.J. The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J. Neurosci. 23 (2003) 7586-7591
27. Langosch D., Becker C.M., and Betz H. The inhibitory glycine receptor: a ligand-gated chloride channel of the central nervous system. Eur. J. Biochem. 194 (1990) 1-8
28. Lindsley C.W., Shipe W.D., Wolkenberg S.E., Theberge C.R., Williams Jr. D.L., Sur C., and Kinney G.G. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr. Top. Med. Chem. 6 (2006) 771-785
29. Liu Q.R., Nelson H., Mandiyan S., Lopez-Corcuera B., and Nelson N. Cloning and expression of a glycine transporter from mouse brain. FEBS Lett. 305 (1992) 110-114
30. Liu W., Leibach F.H., and Ganapathy V. Characterization of the glycine transport system GLYT 1 in human placental choriocarcinoma cells (JAR). Biochim. Biophys. Acta 1194 (1994) 176-184
31. Mackenzie B., Schafer M.K., Erickson J.D., Hediger M.A., Weihe E., and Varoqui H. Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons. J. Biol. Chem. 278 (2003) 23720-23730
32. Martina M., Gorfinkel Y., Halman S., Lowe J.A., Periyalwar P., Schmidt C.J., and Bergeron R. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J. Physiol. 557 (2004) 489-500
33. Nakauchi J., Matsuo H., Kim D.K., Goto A., Chairoungdua A., Cha S.H., Inatomi J., Shiokawa Y., Yamaguchi K., Saito I., Endou H., and Kanai Y. Cloning and characterization of a human brain Na(+)-independent transporter for small neutral amino acids that transports d-serine with high affinity. Neurosci. Lett. 287 (2000) 231-235
34. Nelson N. The family of Na+/Cl- neurotransmitter transporters. J. Neurochem. 71 (1998) 1785-1803
35. Nishino T., Pusey C.D., and Domin J. Elevated Akt phosphorylation as an indicator of renal tubular epithelial cell stress. J. Biol. Chem. 277 (2002) 33943-33949
36. Sakata K., Sato K., Schloss P., Betz H., Shimada S., and Tohyama M. Characterization of glycine release mediated by glycine transporter 1 stably expressed in HEK-293 cells. Brain Res. Mol. Brain Res. 49 (1997) 89-94
37. Smith K.E., Borden L.A., Hartig P.R., Branchek T., and Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8 (1992) 927-935
38. Snell L.D., Morter R.S., and Johnson K.M. Glycine potentiates N-methyl-d-aspartate-induced [3H]TCP binding to rat cortical membranes. Neurosci. Lett. 83 (1987) 313-317
39. Somwar R., Sumitani S., Taha C., Sweeney G., and Klip A. Temporal activation of p70S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Am. J. Physiol. 275 (1998) E618-E625
40. Supplisson S., and Bergman C. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J. Neurosci. 17 (1997) 4580-4590
41. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
42. Whitehead K.J., Pearce S.M., Walker G., Sundaram H., Hill D., and Bowery N.G. Positive N-methyl-d-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo. Neuroscience 126 (2004) 381-390
43. - -dependent neurotransmitter transporter activity. Anal. Biochem. 321 (2003) 31-37
44. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., and Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 7104-7108
45. Yao D., Mackenzie B., Ming H., Varoqui H., Zhu H., Hediger M.A., and Erickson J.D. A novel system A isoform mediating Na+/neutral amino acid cotransport. J. Biol. Chem. 275 (2000) 22790-22797
46. Yee B.K., Balic E., Singer P., Schwerdel C., Grampp T., Gabernet L., Knuesel I., Benke D., Feldon J., Mohler H., and Boison D. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J. Neurosci. 26 (2006) 3169-3181
47. Zafra F., Aragon C., Olivares L., Danbolt N.C., Gimenez C., and Storm-Mathisen J. Glycine transporters are differentially expressed among CNS cells. J. Neurosci. 15 (1995) 3952-3969
48. Zafra F., Gomeza J., Olivares L., Aragon C., and Gimenez C. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur. J. Neurosci. 7 (1995) 1342-1352